3SOF

   Woooah Quasi... Cool Scan.   Much more indepth than mine have been as I've tried to keep them relatively tame but whatever works.  I'll have to run it tonight and see what it pulls up but I'd then likely run the gauntlet of my other signals over the scan results.

As for Aussie Trader and running Automated Scans and using Mechanical Trading (or system trading)....  You may have something there if we were able to write a Scan(s) that was Foolproof,  however if a scan is good but keeps pulling up 80 stocks or so, you need to then keep narrowing down the parameters to scan over and over till you get a short list, kinda like interviewing candidates for a job, eventually getting a top 5 list.  Then add some Fundamental Analysis and we could likely generate some seriously profitable swing trades on the top 3.

Thing is there's a Gazillion parameters to meet everyones trading style so how could we agree on anything?  The other thing is most of here don't day trade, we swing trade so again most anything with a momentum indicator is toast.

I've now got about 6 good scans that I look at periodically but not nearly as much as I'd like.   Perhaps if we put our collective minds together to determine if there are mutual indicators of interest that appear affective and build one scan than encompasses them all...

Would that even be possible?

Next Up.... Powder River Basin........PRVB   

Sorry not sure why my chart wouldn't work....

Scan for the "SMA 5,10,20 Cross" ....
Well guys it's been quite a while since I've been here.
For those of you using the Advanced Scan Interface at StockCharts you can plug these Scan Parameters in and pull up all the charts that fit that description....

[type = stock]and[country = canada]and[daily sma(20,daily volume)>100000]and[yesterdays SMA(5,close<yesterdays SMA(10,close)]and[yesterdays SMA(5,close)<yesterdays SMA(20,close)]and[SMA(5,close)>SMA(10,close)]and[SMA(5,close)>SMA(20,close)]

Now that can be changed if you want..... for US stocks simply remove Canada and put in US. Also if you don't want the 5 day SMA to have crossed the SMA 20 just yet then sub at the end <= instead of the >SMA(20.... so it looks like this...

[type = stock]and[country = US]and[daily sma(20,daily volume)>100000]and[yesterdays SMA(5,close<yesterdays SMA(10,close)]and[yesterdays SMA(5,close)<yesterdays SMA(20,close)]and[SMA(5,close)>SMA(10,close)]and[SMA(5,close)<=SMA(20,close)]

You can also add to the scan to include price ranges of whatever you choose such as.....

[type = stock]and[country = US]and[daily close >= 0.65]and[daily close <=10.00]and[daily sma(20,daily volume)>100000]and[yesterdays SMA(5,close<yesterdays SMA(10,close)]and[yesterdays SMA(5,close)<yesterdays SMA(20,close)]and[SMA(5,close)>SMA(10,close)]and[SMA(5,close)<=SMA(20,close)]

Hope all is well.... Dead

CERS - Cerus is just starting to reverse.  Not a triangle but this website has Waaaaaaay too many freak'n forums and I wasn't sure where would be the best place to post this chart so here it is! ......

If I may be so bold as to criticize, I think you're swing trades are based purely on T/A and not enough on F/A... In combination a swing trade can be explosive and from I've seen your setups have been moderate for a very short term basis as so have your trades...  Find those Really good stories of a stock beaten down for a no good reason such as simply waiting for news....  One such company is Medicure, MPH on the tse or MCU on Amex.  This company is definitely going to anounce a Partnership in the next 4 months and it is likely to be sooner than later as they want the partnership secured prior to starting their Phase3 trials on both their lead drugs  MC-1 and MC-4232...  Don't be in a hurry to make a good/great trade.  Don't rush the profits.  Spend a week without trades on the books and simply do research.  When you find the right one the profits will come.   MPH will hit $2.30 in the next 3 weeks for a minimum 11% after commissions just based on the story below.  Just be patient and then move on to the next great story...

Results at the 21st Annual Meeting of the American Society of Hypertension
4/10/2006

WINNIPEG, MANITOBA, Apr 10, 2006 (CCNMatthews via COMTEX News Network) --
Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company, today announced that two posters outlining the positive results of the Phase II MATCHED study with MC-4232 have been accepted for presentation at ASH 2006. The American Society of Hypertension (ASH) Annual Scientific Meeting and Exposition is being held in New York at the New York City Hilton Hotel from May 16-20, 2006. ASH is the largest U.S. organization dedicated exclusively to hypertension and related cardiovascular disease.
"We look forward to presenting the MATCHED clinical results at this important scientific forum," stated Dr. Lacourciere, MD, FRCP, FACP and Principal Investigator of the MATCHED study. "The opportunity to present the results validates the importance of the study's findings and the expanding need for new approaches to treat patients with diabetes and hypertension."

"This is an ideal setting for our first formal presentation of the MATCHED clinical results," commented Medicure's President and CEO, Albert D. Friesen, PhD. "Patients with coexisting diabetes and hypertension, like those studied in MATCHED, are extremely difficult to treat and frequently require multiple drugs to control their cardiovascular and metabolic risk factors. MC-4232, as demonstrated in MATCHED, is currently one of the only drugs in development that addresses both cardiovascular and metabolic risk factors in this difficult to treat patient population."

Dr. Lacourciere, Director of the Hypertension Research Unit, Centre Hospitalier de l'Universite Laval Sainte-Foy, Quebec will present the two posters describing the antihypertensive and metabolic effects of MC-4232. The abstract titled "Evaluation of the Antihypertensive Effects of MC-1 Alone and in Combination with Lisinopril on Ambulatory BP in Hypertensive Patients with Type 2 Diabetes Mellitus" will be presented at 8:30 AM EST on May 17, 2006. The second abstract titled "The Combination of MC-1 and Lisinopril Has Beneficial Effects on Carbohydrate and Lipid Metabolism in Hypertensives with Type 2 Diabetes Mellitus" will be presented at 4:00 PM EST on May 16, 2006.

Fact is I've spent Hundreds of hours researching this (my favorite) company and will make a fortune on it as it's products complete PH3 and make it to market. But when the Pharmaceutical Partnership is announced this stock will easily vault 75% from wherever it's sitting price wise.

Quote from: Lucas Scott on April 26, 2006, 08:09:26 PM
Grab some if it dips to the 1.50 - 1.55 range and ride it over $2!

My TGC call. Brilliant!

Quote

Muuuahahahahahahahahaha!  Super Strong Resistance at the $2.00 mark.  Major Short coming in at $1.98 with a 62% retracement off the move from $1.25 means the end of the contest sees a price for TGC at $1.53.......   BWTFDIK - My dog CDIC needs a good bath and Beating!..... Just kidding about the bath err I mean the Beating! 

I knew I Should've picked Medicure! lol 

Dag-nabbit!  I jinxed myself  ...lmao

Oh well, there's plenty of time left for a pullback, retest support and upwards and onwards.

When is the last day anyway for the contest?

Moooahhahahahahahahahahahahaha !! 
I like this!   Top 3 runners and they're counting their chickens b4 they've hatched.
Taking out the top 3 positions (TGC) put's me in third place...  Nice start IMHO.
Hard to pick any winners in this market.
But where is Leaira's pick?

My Pic is CDIC - CardioDynamics International Corp.

Summary
CardioDynamics, the ICG Company, is the innovator and leader of breakthrough medical technology called Impedance Cardiography. The company's BioZ Systems are being used by leading physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare and Philips Medical Systems.  

The CEO Michael K. Perry recently stated....
"Despite the weaker than expected first quarter, we are optimistic about our future. We are encouraged by the opening of Medicare's reconsideration process for hypertension and the planned $4 million investment to provide additional cash resources to grow our business. We were very pleased to have the recent publications of two important clinical trials, our 11-center CONTROL study and Cleveland Clinic's ED-IMPACT study. The CONTROL trial demonstrated that BioZ-directed therapy was more than two times better than standard care for achievement of blood pressure control. The ED-IMPACT trial showed that there was a 13% diagnosis change and 39% treatment change in shortness of breath patients when physicians used BioZ data after initial assessment. We also anticipate the June publication of PREDICT, a 21-center ICG prognostic heart failure study, which identified ICG as the most powerful predictor of short-term heart failure hospitalization or death. These three studies represent the strongest scientific evidence in the Company's history which we believe should further drive ICG's clinical importance, visibility, market adoption, and ultimately a broadened national Medicare policy."

April 18, 2006: Various insiders including the CEO of CardioDynamics International Corporation (CDIC) purchased 62,500 shares of CDIC from the open market. CDIC rose 12.80% since the InsiderCow.com report.

Trade amount: 62,500 shares

Trade type: Open Market Buy

Trade price range: $1.23 - $1.26

My Price target is a modest $2.10 in the short term for an expected gain of 35.5%.....

My usual charts for Medicure that I have posted on the Public Charts Forum at StockCharts.com.................  Dead   

Hi all......  Not sure if you may think this Ascending Triangle is a little bit loose with how I've drawn the top but it could be getting ready to make a move...... 

Here's two Stocks trading with extended Bull Flags and both are set to make 20-30% on the breakouts which for both I would expect before the end of April....

Yep that BPUR looked ugly as it was reaching the end of the descending triangle for a Breakdown.  But not nearly as Ugly as RDCM.  Holy Cr@pola.   I guess it had been a few days since I really checked in here and wasn't paying attention.  I wasn't expecting the stock to crash.  Only to stay within the Bearish Pitchfork.  Not nice at all and I hope everyone holding it bailed in advance.

As far as using Log vs Linear style charts.  Plain and simple.  I  find them much easier to read for everything from candles to patterns and anything else inbetween.  I like to stick with what I know.  Took me quit awhile to teach myself T/A online and now I'm so busy applying the little knowledge I have in my free time that I can't go onto the next step without taking some time off from my real job.  I always keep my eyes and ears open however for any new or different methods/signals to make things easier that I haven't perhaps looked at b4.  Dead

Hi Guys.  Sorry but been away.  Will chat later but take a look at BioPure...

The reason I love the candleglance on the scans is because I can add my rising ppo 6,12,6 indicator which is my trigger.  So on the 2 month if the ppo looks vg then I will click on the chart and call up the larger image with all my signals and see if there's any confirmations.  If there are then I know I have a potential winner, write down the symbol, click back on the browser so I'm back into candleglance and go onto the next.  Like I say I can view 2-300 charts in a half hour.   Whatever works...... and that works great for me.  I also watch very closely for the 5day ma to make a cross over the 10 & 20ma's on a 3 month and a 5 minute daily to ensure it's looking rosey...